Stockreport
Incyte (INCY) Beats Q1 Earnings and Revenue Estimates [Yahoo! Finance]
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
This compares to earnings of $1.16 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +31.29%. A quarter ago, it was expected that this specialty drugmaker would post earnings of $1.94 per share when it actually produced earnings of $1.8, delivering a surprise of -7.22%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Incyte, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.27 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 4.21%. This compares to year-ago revenues of $1.05 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Incyte
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | INCY | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
INCY alerts
INCY alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
NEWS
NEWS
- Incyte (INCY) had its price target raised by Stifel Nicolaus from $120.00 to $123.00. They now have a "buy" rating on the stock.[MarketBeat]
- Earnings To Watch: Amgen (AMGN) Reports Q1 Results Tomorrow [Yahoo! Finance][Yahoo! Finance]
- Incyte (INCY) had its "market perform" rating reaffirmed by Oppenheimer Holdings, Inc..[MarketBeat]
- Incyte to Present at Upcoming Investor Conferences[Business Wire]
- Incyte Corp (INCY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Promising ... [Yahoo! Finance][Yahoo! Finance]
- More
INCY
SEC Filings
SEC Filings
- 4/30/26 - Form SCHEDULE
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form ARS
- INCY's page on the SEC website
- More